- $0.58m
- $3.53m
- $4.73m
Annual balance sheet for NewGenIvf, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0.029 | 0.028 | 0.054 | 0.458 | 0.759 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.695 | 2.28 | 0.52 | 1.36 | 1.07 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0.82 | 2.4 | 2.46 | 3.17 | 7.38 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.592 | 0.506 | 0.446 | 0.372 | 2.29 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 1.41 | 2.9 | 4.49 | 3.58 | 32.7 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2.07 | 2.56 | 1.12 | 2.72 | 2.37 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 2.19 | 2.34 | 0.751 | 4.63 | 6.09 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -0.776 | 0.563 | 3.74 | -1.05 | 26.6 |
| Total Liabilities & Shareholders' Equity | 1.41 | 2.9 | 4.49 | 3.58 | 32.7 |
| Total Common Shares Outstanding |